FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4281853250> ?p ?o ?g. }

• W4281853250 abstract "Ferroptosis is a form of programmed cell death (PCD) that has been implicated in cancer progression, although the specific mechanism is not known. Here, we used the latest DepMap release CRISPR data to identify the essential ferroptosis-related genes (FRGs) in glioma and their role in patient outcomes.RNA-seq and clinical information on glioma cases were obtained from the Chinese Glioma Genome Atlas (CGGA) and The Cancer Genome Atlas (TCGA). FRGs were obtained from the FerrDb database. CRISPR-screened essential genes (CSEGs) in glioma cell lines were downloaded from the DepMap portal. A series of bioinformatic and machine learning approaches were combined to establish FRG signatures to predict overall survival (OS) in glioma patients. In addition, pathways analysis was used to identify the functional roles of FRGs. Somatic mutation, immune cell infiltration, and immune checkpoint gene expression were analyzed within the risk subgroups. Finally, compounds for reversing high-risk gene signatures were predicted using the GDSC and L1000 datasets.Seven FRGs (ISCU, NFS1, MTOR, EIF2S1, HSPA5, AURKA, RPL8) were included in the model and the model was found to have good prognostic value (p < 0.001) in both training and validation groups. The risk score was found to be an independent prognostic factor and the model had good efficacy. Subgroup analysis using clinical parameters demonstrated the general applicability of the model. The nomogram indicated that the model could effectively predict 12-, 36-, and 60-months OS and progression-free interval (PFI). The results showed the presence of more aggressive phenotypes (lower numbers of IDH mutations, higher numbers of EGFR and PTEN mutations, greater infiltration of immune suppressive cells, and higher expression of immune checkpoint inhibitors) in the high-risk group. The signaling pathways enriched closely related to the cell cycle and DNA damage repair. Drug predictions showed that patients with higher risk scores may benefit from treatment with RTK pathway inhibitors, including compounds that inhibit RTKs directly or indirectly by targeting downstream PI3K or MAPK pathways.In summary, the proposed cancer essential FRG signature predicts survival and treatment response in glioma." @default.
• W4281853250 created "2022-06-13" @default.
• W4281853250 creator A5010738468 @default.
• W4281853250 creator A5018867577 @default.
• W4281853250 creator A5021052031 @default.
• W4281853250 creator A5034855502 @default.
• W4281853250 creator A5039486491 @default.
• W4281853250 creator A5049341927 @default.
• W4281853250 creator A5060211121 @default.
• W4281853250 creator A5068274253 @default.
• W4281853250 creator A5069631018 @default.
• W4281853250 creator A5072214735 @default.
• W4281853250 creator A5075873887 @default.
• W4281853250 creator A5080222399 @default.
• W4281853250 creator A5083706310 @default.
• W4281853250 creator A5084587848 @default.
• W4281853250 creator A5085352453 @default.
• W4281853250 creator A5086326013 @default.
• W4281853250 creator A5088068064 @default.
• W4281853250 creator A5091145607 @default.
• W4281853250 date "2022-06-10" @default.
• W4281853250 modified "2023-10-06" @default.
• W4281853250 title "A Novel Prognostic Signature Based on Glioma Essential Ferroptosis-Related Genes Predicts Clinical Outcomes and Indicates Treatment in Glioma" @default.
• W4281853250 cites W1861033863 @default.
• W4281853250 cites W1981073960 @default.
• W4281853250 cites W1984507712 @default.
• W4281853250 cites W1990098395 @default.
• W4281853250 cites W1990317973 @default.
• W4281853250 cites W1997183854 @default.
• W4281853250 cites W2006178088 @default.
• W4281853250 cites W2006559495 @default.
• W4281853250 cites W2018193678 @default.
• W4281853250 cites W2023012828 @default.
• W4281853250 cites W2091415498 @default.
• W4281853250 cites W2097360283 @default.
• W4281853250 cites W2108068107 @default.
• W4281853250 cites W2113189027 @default.
• W4281853250 cites W2123664981 @default.
• W4281853250 cites W2157947153 @default.
• W4281853250 cites W2164871149 @default.
• W4281853250 cites W2179438025 @default.
• W4281853250 cites W2263206910 @default.
• W4281853250 cites W2345452469 @default.
• W4281853250 cites W2359562008 @default.
• W4281853250 cites W2406250479 @default.
• W4281853250 cites W2426347188 @default.
• W4281853250 cites W2565750356 @default.
• W4281853250 cites W2597819563 @default.
• W4281853250 cites W2600317738 @default.
• W4281853250 cites W2612467560 @default.
• W4281853250 cites W2735132087 @default.
• W4281853250 cites W2749856153 @default.
• W4281853250 cites W2770709665 @default.
• W4281853250 cites W2795989238 @default.
• W4281853250 cites W2805955117 @default.
• W4281853250 cites W2883808647 @default.
• W4281853250 cites W2895831326 @default.
• W4281853250 cites W2896872272 @default.
• W4281853250 cites W2937818441 @default.
• W4281853250 cites W2938298976 @default.
• W4281853250 cites W2975379509 @default.
• W4281853250 cites W2982434722 @default.
• W4281853250 cites W2999304067 @default.
• W4281853250 cites W3008330096 @default.
• W4281853250 cites W3013967177 @default.
• W4281853250 cites W3015311874 @default.
• W4281853250 cites W3023889570 @default.
• W4281853250 cites W3027286012 @default.
• W4281853250 cites W3030372837 @default.
• W4281853250 cites W3048398332 @default.
• W4281853250 cites W3060535570 @default.
• W4281853250 cites W3081135066 @default.
• W4281853250 cites W3088229934 @default.
• W4281853250 cites W3091831810 @default.
• W4281853250 cites W3094771195 @default.
• W4281853250 cites W3101338849 @default.
• W4281853250 cites W3129076196 @default.
• W4281853250 cites W3161919037 @default.
• W4281853250 cites W3173874300 @default.
• W4281853250 cites W3175752499 @default.
• W4281853250 cites W3199116415 @default.
• W4281853250 cites W3211428918 @default.
• W4281853250 cites W3216148020 @default.
• W4281853250 cites W4205903917 @default.
• W4281853250 cites W4206921112 @default.
• W4281853250 cites W4206972726 @default.
• W4281853250 cites W4210668295 @default.
• W4281853250 cites W4210674607 @default.
• W4281853250 cites W4226289755 @default.
• W4281853250 cites W4294541781 @default.
• W4281853250 doi "https://doi.org/10.3389/fonc.2022.897702" @default.
• W4281853250 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35756689" @default.
• W4281853250 hasPublicationYear "2022" @default.
• W4281853250 type Work @default.
• W4281853250 citedByCount "7" @default.
• W4281853250 countsByYear W42818532502022 @default.
• W4281853250 countsByYear W42818532502023 @default.
• W4281853250 crossrefType "journal-article" @default.
• W4281853250 hasAuthorship W4281853250A5010738468 @default.
• W4281853250 hasAuthorship W4281853250A5018867577 @default.

• next